搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Ehrlichia canis 50S ribosomal protein L4 (rplD) CSB-YP668949EAAI
CSB-EP668949EAAI
CSB-BP668949EAAI
CSB-MP668949EAAI
CSB-EP668949EAAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ehrlichia canis 50S ribosomal protein L14 (rplN) CSB-YP668950EAAI
CSB-EP668950EAAI
CSB-BP668950EAAI
CSB-MP668950EAAI
CSB-EP668950EAAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ehrlichia canis 30S ribosomal protein S13 (rpsM) CSB-YP668951EAAI
CSB-EP668951EAAI
CSB-BP668951EAAI
CSB-MP668951EAAI
CSB-EP668951EAAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ehrlichia canis Phosphate acyltransferase (plsX) CSB-YP668952EAAI
CSB-EP668952EAAI
CSB-BP668952EAAI
CSB-MP668952EAAI
CSB-EP668952EAAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ehrlichia canis Deoxyuridine 5'-triphosphate nucleotidohydrolase (dut) CSB-YP668953EAAI
CSB-EP668953EAAI
CSB-BP668953EAAI
CSB-MP668953EAAI
CSB-EP668953EAAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ehrlichia canis Ribosomal RNA small subunit methyltransferase H (rsmH) CSB-YP668954EAAI
CSB-EP668954EAAI
CSB-BP668954EAAI
CSB-MP668954EAAI
CSB-EP668954EAAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ehrlichia canis Translation initiation factor IF-2 (infB), partial CSB-YP668955EAAI
CSB-EP668955EAAI
CSB-BP668955EAAI
CSB-MP668955EAAI
CSB-EP668955EAAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ehrlichia canis NADH-quinone oxidoreductase subunit D (nuoD) CSB-YP668956EAAI
CSB-EP668956EAAI
CSB-BP668956EAAI
CSB-MP668956EAAI
CSB-EP668956EAAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ehrlichia canis Ferredoxin--NADP reductase (Ecaj_0391) CSB-YP668957EAAI
CSB-EP668957EAAI
CSB-BP668957EAAI
CSB-MP668957EAAI
CSB-EP668957EAAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ehrlichia canis Probable transcriptional regulatory protein Ecaj_0351 (Ecaj_0351) CSB-YP668958EAAI
CSB-EP668958EAAI
CSB-BP668958EAAI
CSB-MP668958EAAI
CSB-EP668958EAAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ehrlichia canis Cysteine--tRNA ligase (cysS) CSB-YP668959EAAI
CSB-EP668959EAAI
CSB-BP668959EAAI
CSB-MP668959EAAI
CSB-EP668959EAAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ehrlichia canis Phosphomethylpyrimidine synthase (thiC), partial CSB-YP668960EAAI
CSB-EP668960EAAI
CSB-BP668960EAAI
CSB-MP668960EAAI
CSB-EP668960EAAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ehrlichia canis Recombination protein RecR (recR) CSB-YP668961EAAI
CSB-EP668961EAAI
CSB-BP668961EAAI
CSB-MP668961EAAI
CSB-EP668961EAAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ehrlichia canis ATP-dependent Clp protease proteolytic subunit (clpP) CSB-YP668962EAAI
CSB-EP668962EAAI
CSB-BP668962EAAI
CSB-MP668962EAAI
CSB-EP668962EAAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ehrlichia canis DNA-directed RNA polymerase subunit beta' (rpoC), partial CSB-YP668963EAAI
CSB-EP668963EAAI
CSB-BP668963EAAI
CSB-MP668963EAAI
CSB-EP668963EAAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ehrlichia canis Alanine--tRNA ligase (alaS), partial CSB-YP668964EAAI
CSB-EP668964EAAI
CSB-BP668964EAAI
CSB-MP668964EAAI
CSB-EP668964EAAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ehrlichia canis ATP synthase subunit alpha (atpA), partial CSB-YP668965EAAI
CSB-EP668965EAAI
CSB-BP668965EAAI
CSB-MP668965EAAI
CSB-EP668965EAAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ehrlichia canis Chaperone protein DnaJ (dnaJ) CSB-YP668966EAAI
CSB-EP668966EAAI
CSB-BP668966EAAI
CSB-MP668966EAAI
CSB-EP668966EAAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shigella sonnei Purine nucleoside phosphorylase DeoD-type (deoD) CSB-YP668967SGI
CSB-EP668967SGI
CSB-BP668967SGI
CSB-MP668967SGI
CSB-EP668967SGI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shigella sonnei Peptide chain release factor 3 (prfC), partial CSB-YP668968SGI
CSB-EP668968SGI
CSB-BP668968SGI
CSB-MP668968SGI
CSB-EP668968SGI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>